13K views · 186 reactions | Metastatic, castration-resistant prostate cancer is associated with decreased overall survival, worsening quality of life, and increased health care–related costs, and bone metastases develop in about a third of patients within 2 years after diagnosis. New research findings are summarized in a short video. https://nej.md/36J2zP8 | The New England Journal of Medicine | Facebook